Legal Opinion
Dobbs v. Wyeth Pharmaceuticals
District Court, W.D. Oklahoma
Decided June 13, 2011No. Case CIV-04-1762-FPublishedCited by 19 opinions
1Opinion of the Court
ORDER
STEPHEN P. FRIOT, District Judge.
Before the Court is the renewed motion for partial summary judgment (doc. no. 266) of Defendant Wyeth Pharmaceuticals (“Wyeth”). The renewed motion was filed following the Tenth Circuit’s decision vacating the court’s January 17, 2008 Order 1 granting Wyeth’s motion for partial summary judgment based on the conclusion that plaintiffs common law failure-to-warn claims are preempted by the United States Food and Drug Administration (“FDA”) regulations governing the content of labels accompanying FDA-approved prescription drugs.
While plaintiffs interlocutory…
2Cases cited16 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Cipollone v. Liggett Group, Inc.Supreme Court of the United States · 1992
- Watters v. Wachovia Bank, N. A.Supreme Court of the United States · 2007
- Fidelity Federal Savings & Loan Ass'n v. De La CuestaSupreme Court of the United States · 1982
11 more not listed; retrieve them via the Exa API.
3Cited by19 opinions
- Cerveny v. Aventis, Inc.Court of Appeals for the Tenth Circuit · 2017
- Reckis v. Johnson & JohnsonMassachusetts Supreme Judicial Court · 2015
- In Re Fosamax (Alendronate Sodium) Products Liability LitigationCourt of Appeals for the Third Circuit · 2017
- Koho v. Forest Laboratories, Inc.District Court, W.D. Washington · 2014
- Rheinfrank v. Abbott Laboratories, Inc.District Court, S.D. Ohio · 2015
14 more not listed; retrieve them via the Exa API.